<DOC>
	<DOCNO>NCT00917735</DOCNO>
	<brief_summary>RATIONALE : Green tea extract contain ingredient ( catechin ) may lower risk breast cancer . PURPOSE : This phase II trial study well green tea extract work prevent breast cancer compare placebo postmenopausal woman high breast density . The investigator hypothesize green tea consumption reduces breast cancer risk , effect see primarily woman low-activity COMT genotype . The investigator test evaluate effect green tea extract breast cancer biomarkers include mammographic density , plasma insulin-like growth factor 1 ( IGF-1 ) , IGF bind protein 3 ( IGFBP-3 ) , estrone , estradiol , androstenedione , sex hormone bind globulin ( SHBG ) , urinary estrogen metabolite plasma F2-isoprostanes .</brief_summary>
	<brief_title>Green Tea Reduction Breast Cancer Risk</brief_title>
	<detailed_description>OBJECTIVES : 1 . Primary : 1.1 To determine effect green tea extract consumption ( contain 800 mg EGCG per day ) 12 month follow recognize biomarkers breast cancer risk : 1 . Mammographic density 2 . Circulating concentration insulin-like growth factor 1 ( IGF-1 ) IGF bind protein 3 ( IGFBP-3 ) 3 . Circulating concentration reproductive hormone ( estrone , estradiol , androstenedione ) sex hormone bind globulin ( SHBG ) 1.2 To determine effect COMT genotype green tea extract effect describe . 2 . Secondary : 2.1 To determine effect green tea extract consumption ( contain 800 mg EGCG per day ) 12 month follow hypothesized biomarkers breast cancer risk : 1 . Urinary estrogen metabolite ( estrone , estradiol , 2-hydroxy , 4-hydroxy , 2-methoxy , 4-methoxy metabolite , estriol , 16- hydroxyestrone ) 2 . Circulating concentration F-2 isoprostanes , recognize biomarker systemic oxidative stress 2.2 To determine effect COMT genotype green tea extract effect describe . 2.3 To determine effect COMT genotype catechin metabolism excretion , measure circulate urinary concentration .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Signed informed consent Healthy postmenopausal woman age 5070 year `` Heterogeneously dense '' ( 5175 % glandular ) `` extremely dense '' ( &gt; 75 % glandular ) breast Willing avoid consumption green tea 1 year Positive serological marker hepatitis B hepatitis C infection Elevated level liver enzymes Recent ( within 6 mo ) current hormone hormone modification therapy , include systemic hormone replacement therapy , SERMS aromatase inhibitor Current smoker cigarettes tobacco product BMI &lt; 19 &gt; 40 kg/m2 Weight change &gt; 10 lb previous year History breast cancer proliferative breast disease Regular consumption &gt; 7 alcoholic drinks/wk Regular consumption green tea ( &gt; 1 cup/wk ) Recent ( within 6 mo ) current use chemopreventive agent tamoxifen , raloxifene aromatase inhibitor Participation weight loss weight gain study Currently take Methotrexate Enbrel History ovarian cancer Any form cancer last 5 year Presence implant</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Green tea</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Prevention</keyword>
	<keyword>COMT genotype</keyword>
	<keyword>EGCG ( Epigallocatechin gallate )</keyword>
	<keyword>Mammographic density</keyword>
	<keyword>Reproductive hormone</keyword>
	<keyword>IGF axis protein</keyword>
	<keyword>Oxidative stress</keyword>
</DOC>